Beacon Gene Therapy

How the most complete clinical trial and drug landscape for Gene Therapies can help you

What we cover

Beacon Gene Therapy is a manually curated database solution that includes clinical trial and drug records for preclinical, active, approved, and discontinued:

  • RNA/DNA Viral vector based therapies
  • DNA Non-viral vector based therapies
  • Genetically Modified cell therapies
  • Empty Vector Trials
  • Other comparable modalities within gene therapy whether cell-free or cell-based
  • Will not cover CAR-T or Non-CAR-T oncology therapies (This is covered in Beacon Adoptive Cell)
  • Beacon Gene Therapy covers all genetically driven non-oncology indications that utilize gene therapy to mediate the condition.

How Beacon helps

Here are a few example use cases that have benefitted our clients in accelerating their Gene Therapy development programs:

  • Benchmark drug development and clinical trial strategies against competitors.
  • Getting an in-depth competitive landscape overview of the competitors and their assets in the clinic.
  • Drastically reduce manual research time with our database solution which allows users to rapidly assemble data for analysis on phase distribution, gene editing technologies, and much more.
  • Identify new players and new assets in entering the clinic and monitor their progress.

How Beacon Gene Therapy works

Search the clinical trial and drug landscape by cell source and type (autologous vs. allogeneic), by gene/mutation, by editing technology (CRISPR/Cas9, Cas-CLOVER, etc.), or gene delivery system, etc, instantaneously and/or extract the data points you need to conduct more complex analysis.

If publicly available, information regarding immunogenicity is included (unique to Beacon Gene Therapy)

  • Types of responses that would qualify within immunogenicity:
    • Anti-Capsid Antibodies
    • Anti-Transgene Antibodies
    • Anti-Capsid Neutralizing Antibodies
    • Anti-Capsid or Anti-Transgene cytokine production
    • IgG or IgM levels assessed pre or post-treatment
    • Immune cell population ratio before and after treatment

 

How we target the data

We house all publicly available sources of data updated with 24 – 48 hours of publication proactively.  Our sources cover (but are not limited to):

  • Clinical trials registries
  • Scientific journals and publications
  • Company reports and presentations
  • Press releases
  • Conference reports and abstracts
  • Government and regulatory organizations
  • Newspapers and other media
  • Patents

Related content

Gene Therapy Webinar 2021

Find out more

Gene Therapy Infographic 2021

Find out more

Gene Therapy Infographic 2020

Find out more

What our customers say

Beacon is a great database that people should pay attention to. It's much better than many of the more generic databases that try to capture all data about everything

Director
Top Biotech Company

Our Gene Therapy Expert

Alexandra Watt is the lead research analyst for Gene Therapies in the Beacon Targeted Therapies teams.

Sign up for her weekly newsletter with the latest Gene Therapy landscape with data from Beacon Gene Therapy.

Subscribe to newsletter

Other Beacon Solutions

ADC
Adoptive Cell
Bispecific
Cancer Vaccine
Checkpoint
Cytokine
DDR
RNA
Oncolytic Viruses
TPD
Beacon ADC Logo

 

Covering all Antibody Drug Conjugates (ADCs), Small Molecule Drug Conjugates (SMDCs), Protein Drug Conjugates (PDCs), Immunotoxins and more

Find out more

Beacon Adoptive Cell Logo

 

Covering all engineered and non-engineered immune cell therapies, including CAR-T, TCR, NK, TILs, Gamma-Delta T Cells and more

Find out more

Beacon Bispecific Logo

 

Covering all Bi- and Multi-Specific Antibodies, Antibody Fragments, Augmented Antibodies and more

Find out more

Cancer Vaccine Logo 2021

 

Beacon Cancer Vaccine provides the solution you need to master the prophylactic and therapeutic cancer vaccines field.

Find out more

Beacon Checkpoint Logo

 

Covering all Immune Checkpoint Combination Trials and Immune Checkpoint Modulators in development across 27 different checkpoint targets

Find out more

 

Covering all cytokines and drugs that target a cytokine or its immediate receptor belonging to the Interleukins, Interferons, Colony-stimulating factors, Transforming growth factor β, Tumour necrosis factor and Chemokines families.

Find out more

Beacon DDR Logo

 

Beacon DDR steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the DDR field.

Find out more

 

Covering Oligonucleotide-based, mRNA-Based, Ribozyme, and gRNA-Mediated Gene Editing therapies, as well as RNA-Targeted Small Molecules – Beacon RNA covers all disease indications and many modalities to provide a detailed landscape of the RNA space.

Find out more

Beacon Oncolytic Viruses Logo

 

From capturing viral family and strains to understanding any genetic modifications – Beacon Oncolytic Viruses steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the Oncolytic Virus field.

Find out more

Beacon TPD Logo

 

Beacon TPD provides the solution you need to master the targeted protein degradation field.

Find out more

Any questions? Contact us

To learn more about how we can tailor Beacon Gene Therapy to help you, get in touch with our sales team

Paulina Szymanska Gregory Kavalerov

Paulina Szymanska & Gregory Kavalerov

Gene Therapy Account Managers

Contact the Team

About Beacon Targeted Therapies

We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.

logo